NeuroPace (NPCE) Gains from Investment Securities (2020 - 2026)
NeuroPace has reported Gains from Investment Securities over the past 7 years, most recently at -$165000.0 for Q1 2026.
- For Q1 2026, Gains from Investment Securities fell 8150.0% year-over-year to -$165000.0; the TTM value through Mar 2026 reached -$177000.0, down 120.14%, while the annual FY2025 figure was -$14000.0, 101.59% down from the prior year.
- Gains from Investment Securities for Q1 2026 was -$165000.0 at NeuroPace, down from -$12000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $10.7 million in Q3 2022 and troughed at -$817000.0 in Q1 2023.
- A 5-year average of $875230.8 and a median of $96000.0 in 2024 define the central range for Gains from Investment Securities.
- Biggest five-year swings in Gains from Investment Securities: surged 721.43% in 2022 and later crashed 8150.0% in 2026.
- Year by year, Gains from Investment Securities stood at $115000.0 in 2022, then soared by 383.48% to $556000.0 in 2023, then soared by 58.45% to $881000.0 in 2024, then plummeted by 101.36% to -$12000.0 in 2025, then tumbled by 1275.0% to -$165000.0 in 2026.
- Business Quant data shows Gains from Investment Securities for NPCE at -$165000.0 in Q1 2026, -$12000.0 in Q4 2025, and -$2000.0 in Q1 2025.